Literature DB >> 3343986

Chloroquine myopathy and myasthenia-like syndrome.

A Sghirlanzoni1, R Mantegazza, M Mora, D Pareyson, F Cornelio.   

Abstract

A young woman on chronic corticosteroid treatment for systemic lupus erythematosus developed a myasthenia-like syndrome 7 weeks after starting chloroquine therapy. Discontinuation of chloroquine allowed symptomatic and immunological remission within 6 months. Ocular symptoms reappeared following a second short course of chloroquine. A motor-point biopsy revealed a vacuolar myopathy with membranous bodies in intramuscular nerves. We discuss the possible role of chloroquine in the pathogenesis of a myasthenia-like syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343986     DOI: 10.1002/mus.880110205

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?

Authors:  Arunmozhimaran Elavarasi; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

Review 3.  New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.

Authors:  Tsubasa Takizawa; Marenori Kojima; Shigeaki Suzuki; Takashi Osada; Satoshi Kitagawa; Jin Nakahara; Shinichi Takahashi; Norihiro Suzuki
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

4.  Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes.

Authors:  Elie Naddaf; Pritikanta Paul; Omar F AbouEzzeddine
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

5.  MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine.

Authors:  Shalini Bhaskar; Mohammed Fauzi Bin Abdul Rani
Journal:  Case Rep Med       Date:  2022-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.